Tuesday, January 7, 2014
Recurrent ovarian cancer "" corresponds to the decitabine and reprogramming after cancer vaccines.
Chemotherapy and cancer vaccines administered prior to treatment with the drug decitabine is Journal of the American Association for cancer research, cancer immunology, Research Institute at Roswell Park cancer published was obtained for women with recurrent ovarian cancer is suggested to provide a treatment option for patients with this disease combination vaccine research Institute, this new clinical effects.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment